Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-10 of 10
Keywords: Antithrombin III
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Gynecol Obstet Invest (1983) 15 (3): 153–162.
Published Online: 16 March 2010
...Jørgen Jespersen; Steen Ingeberg; Elsa Bach Determinations of platelet number and concentration of antithrombin III (AT-III) were made in samples of plasma collected during one normal or hormone-simulated cycle in 14 young, normal women and in 11 women using an oral contraceptive low in oestrogen...
Journal Articles
Gynecol Obstet Invest (1983) 16 (2): 107–118.
Published Online: 16 March 2010
... been reported in the literature. Disseminated intravascular coagulation (DIC) has been suggested as a contributing cause to the high mortality. The treatment of DIC has long been under debate, and recently the administration of antithrombin III (AT) concentrate in addition ot other supportive treatment...
Journal Articles
Gynecol Obstet Invest (1983) 16 (4): 230–242.
Published Online: 16 March 2010
...G.H. Weenink; J.J.J. Borm; Ten Cate; P.E. Treffers Antithrombin III (AT III) is the main physiological inhibitor of blood coagulation. In a prospective study, plasma AT III was determined in 653 women during pregnancy, using an automated amidolytic technique. A control value 8 weeks after delivery...
Journal Articles
Gynecol Obstet Invest (1987) 24 (3): 170–178.
Published Online: 15 March 2010
...Takao Kobayashi; Toshihiko Terao Determinations of coagulation/fibrinolysis parameters thrombin-antithrombin III complex (TAT) and D-dimers (cross-linked fibrin degradation product) were carried out in order to prove that preeclampsia is a chronic disseminated intravascular coagulation (DIC) state...
Journal Articles
Gynecol Obstet Invest (1988) 26 (3): 181–190.
Published Online: 02 March 2010
...Masaaki Hayakawa; Masahiro Maki The relationship between the hemostatic system and the severity of toxemia was studied in 78 pregnant women with toxemia. The activities of plasma antithrombin III (AT-III), prekaUikrein, plasminogen, Α 2 -plasmin inhibitor and factor XIII were determined using...
Journal Articles
Gynecol Obstet Invest (1990) 30 (2): 87–90.
Published Online: 02 March 2010
...T.T. Lao; J.A. Yin; W.K. Ng; P.M.P. Yuen The relationship between plasma levels of protein C, protein S and antithrombin III was examined in a group of normal pregnant Chinese women with singleton pregnancies to study the changes in the anticoagulant system in relation to pregnancy, labour...
Journal Articles
Toshihiko Terao, Masahiro Maki, Tsuyomu Ikenoue, Kaoru Gotoh, Makoto Murata, Hirokazu Iwasaki, Jiroh Shibata, Masao Nakabayashi, Mitsue Muraoka, Yoshihiko Takeda, Shoichi Sakamoto, Takao Kobayashi, Nobuaki Imai, Hiroyuki Oda, Hiroshi Sameshima
Gynecol Obstet Invest (1991) 31 (2): 74–85.
Published Online: 02 March 2010
... of pregnancy was investigated in comparison with normal pregnant women using new coagulation parameters, mainly thrombin-antithrombin III (TAT) complexes, Α 2 -antiplasmin-plasmin complexes (PIP), and D-dimer FDP. When the patients were categorized by the classification of the WHO Study Group (1985...
Journal Articles
Abdul Halim, A.B. Bhuiyan, Faruque A. Azim, Selina Khatun, Naohiro Kanayama, Emad El Maradny, Kayoho Maehara, Kobayashi Hiroshi, Toshihiko Terao
Gynecol Obstet Invest (1995) 39 (2): 97–102.
Published Online: 01 March 2010
..., instructions or products referred to in the content or advertisements. Eclampsia Thrombin antithrombin complexes Antithrombin III D dimer fibrin degradation product α 2 -Plasmin inhibitor-plasmin complex Original Paper Gynecol Obstet Invest 1995;39:97-102 Abdul Halima A B. Bhuiyanb FaruqueA. A zim...
Journal Articles
Gynecol Obstet Invest (1997) 43 (1): 29–33.
Published Online: 26 February 2010
...Mieczyslaw Uszyński; Andrzej Kielkowski; Waldemar Uszyński; Ewa Zekanowska We measured thrombin-antithrombin III (TAT) complexes and antithrombin III (AT III) in amniotic fluid and blood plasma of 39 parturient women. TAT was measured by ELISA. Partigen plates were used for measuring the antigen...
Journal Articles
Gynecol Obstet Invest (2001) 52 (1): 47–50.
Published Online: 14 September 2001
... levels of antithrombin III (AT III) activity, thrombin-antithrombin complex (TAT) and D-dimer were correlated with each placental grade. AT III activity levels tended to decrease with advancing placental grade from I to III (p < 0.05). D-dimer showed the same tendency while TAT did not. The incidence...